A single, extinction-based treatment with a kappa opioid receptor agonist elicits a long-term reduction in cocaine relapse | Neuropsychopharmacology
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Selective kappa opioid antagonists for treatment of addiction, are we there yet? - ScienceDirect
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Opioids - Pharmacology Flashcards | Draw it to Know it
Study provides clues for designing new anti-addiction medications | National Institutes of Health (NIH)
The Kappa Opioid Receptor: From Addiction to Depression, and Back | Semantic Scholar
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
κ-opioid receptor - Wikipedia
κ-opioid receptor - Wikipedia
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction | Neuropsychopharmacology
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Opioid agonists, mixed agonist-antagonists and partial agonists | Osmosis
